Researchers at Dana-Farber/Boston Children's collaborate with doctors and researchers around the world to provide advanced care in more specialties and subspecialties, more expertise in every facet of care for cancer and blood disorders, and more cutting-edge treatment options. Thanks in part to these collaborations, we're introducing promising new drugs and opening worldwide clinical trials that break new ground across the spectrum of cancer and blood disorders — like our protocols targeted for relapsed acute lymphoblastic leukemia, molecular profiling of brainstem gliomas, bone marrow transplantation for dyskeratosis congenita, and immunotherapy for relapsed neuroblastoma.
At any given time we are sponsoring and collaborating on over 100 pediatric cancer and blood disorder clinical trials.
Blood Disorder (Hematology) Clinical Trials
Relapsed Cancer Clinical Trials
Brain Tumor Clinical Trials
Histiocytosis Clinical Trials
Leukemia Clinical Trials
Lymphoma Clinical Trials
Solid Tumor Clinical Trials
Stem Cell Transplant and Gene Therapy Clinical Trials
Stay informed about our clinical trials and ongoing research. Sign up to receive our email newsletter.